ROP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Roper Technologies Inc (ROP) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock is currently in a bearish technical trend, with oversold conditions, weak financial performance in the latest quarter, and a lack of strong positive catalysts. Analysts have broadly lowered price targets, and there are significant concerns about growth visibility and competitive risks. While hedge funds are buying, the overall sentiment and data do not suggest a compelling entry point for long-term investment.
The stock is in a bearish trend with MACD negatively expanding (-3.156), RSI indicating oversold conditions (18.735), and bearish moving averages (SMA_200 > SMA_20 > SMA_5). Key support levels are at S1: 326.295 and S2: 312.633, with resistance levels significantly higher at R1: 370.523 and R2: 384.185. The pre-market price is $320.2, showing a slight increase of 0.12%, but this does not indicate a reversal of the bearish trend.
Hedge funds are significantly increasing their positions in the stock, with a 108.14% increase in buying over the last quarter. The company's gross margin improved to 69.46% in Q4 2025, up 1.68% YoY.
Analysts have broadly lowered price targets, citing weak Q4 organic growth, subdued FY25 guidance, and mounting competitive risks related to AI adoption. The company's net income and EPS declined YoY in Q4 2025, and the stock is underperforming technically. There is no recent news or congress trading data to act as a catalyst.
In Q4 2025, revenue increased by 9.67% YoY to $2.0586 billion, but net income dropped by 7.33% YoY to $428.4 million, and EPS fell by 7.24% YoY to $3.97. While gross margin improved to 69.46%, the overall financial performance reflects slowing growth and declining profitability.
Analysts have downgraded the stock and lowered price targets significantly. Goldman Sachs, Mizuho, and Barclays have expressed concerns about limited near-term growth visibility, competitive risks, and subdued organic growth. While some firms like Baird and Jefferies maintain a Buy rating, they have also reduced price targets, reflecting cautious optimism.
